Yasuo Miyake

This inventor holds 18 USPTO granted patents, primarily in Pharmaceutical Formulations. Top assignees: Eisai Company, Limited, Kabushiki Kaisha Tokai Rika Denki Seisakusho. Active years: 1982-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yasuo Miyake. Retrieved from https://idiyas.com/inventor/yasuo-miyake-yfy03cjs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 8

Forward Citations = 240(Granted Patents)

Location History:

Ichinomiya, JP (1988)
Ibaraki, JP (1992)
Inuyama, JP (1982 - 1995)
Aichi Prefecture, JP (1996)
Aichi, JP (1986 - 1999)

Company Filing History:

15 out of 677

Eisai Company, Limited

patents

3 out of 2,031

Kabushiki Kaisha Tokai Rika Denki Seisakusho

patents

Years Active: 1982-1999

Loading Chart...

Areas of Expertise:

Sustained-Release Tablets

Prostaglandin Conjugates

Optical Isomer Separation

tPA Compositions

Granule Drug Preparation

Rotary Shaft Coupling

Automotive Steering

Cyclodextrin Compounds

Gelatin Capsule Sealing

Cobamamide Formulations

Absorption Enhancement

Multi-Granule Systems

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5975963 - Female terminal (1999-11-02),

2. 5624683 - Sustained-release multi-granule tablet (1997-04-29),

3. 5576021 - Sustained-release multi-granule tablet (1996-11-19),

4. 5425943 - Modified tPA-containing injection composition having increased solubility (1995-06-20),

5. 5120719 - Conjugate of prostaglandin and polysaccharide (1992-06-09),

6. 5093200 - Multilayer sustained release granule (1992-03-03),

7. 5030455 - Sustained-release drug preparation (1991-07-09),

8. 5030354 - Separation agent for optical isomers (1991-07-09),

9. 4985245 - tPA-containing medical composition (1991-01-15),

10. 4844905 - Granule remaining in stomach (1989-07-04),

11. 4837022 - Composition containing tissue plasminogen activator (1989-06-06),

12. 4827062 - Composition containing ubidecarenone with absorption promoted (1989-05-02),

13. 4806809 - Rotary shaft coupling device (1989-02-21),

14. 4753599 - Automotive steering assembly (1988-06-28),

15. 4598070 - Tripamide and cyclodextrin inclusion compound (1986-07-01),

Title: Yasuo Miyake: Innovator in Pharmaceutical Technology

Introduction

Yasuo Miyake is a prominent inventor based in Aichi, Japan. He has made significant contributions to the field of pharmaceutical technology, holding a total of 18 patents. His work focuses on improving drug delivery systems, which has a profound impact on patient care and treatment efficacy.

Latest Patents

One of his latest inventions is a female terminal - a sustained-release multi-granule tablet. This innovative tablet is created by compressing sustained-release granules that contain a basis and a formulation adjuvant. Each granule is pre-coated with a layer of the formulation adjuvant and/or a mixture of the formulation adjuvant and the basis. The design of this tablet allows for the active substance to be released at a suitable velocity into the digestive tract. This minimizes the imbalance in drug absorption among patients, thereby achieving maximum bioavailability.

Career Highlights

Throughout his career, Yasuo Miyake has worked with notable companies in the pharmaceutical industry. He has been associated with Eisai Company, Limited and Tokai Rika Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug formulation and delivery.

Collaborations

Yasuo Miyake has collaborated with several talented individuals in his field. Notable coworkers include Sumio Watanabe and Takayuki Ohwaki, who have contributed to his projects and innovations.

Conclusion

Yasuo Miyake's contributions to pharmaceutical technology through his patents and collaborations highlight his role as an influential inventor. His work continues to enhance drug delivery systems, ultimately benefiting patients worldwide.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]